Brain imaging of 18F‐fallypride in normal volunteers: Blood analysis, distribution, test‐retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D‐2/D‐3 receptors
Abstract
Human studies of dopamine D2/D3 receptors using 18F‐fallypride‐PET in normal volunteers were performed to evaluate brain distribution in striatal and extrastriatal regions, evaluate metabolites in blood plasma, establish PET imaging protocol for this new radiotracer, evaluate graphical methods of analysis to quantitate D2/D3 receptors, and assess the ability of 18F‐fallypride to measure changes in D2/D3 receptors with aging as a model. Subjects (6; 21–63 years) had a PET scan on a Siemens HR+ scanner with 18F‐fallypride and a T1‐weighted MRI scan on a 1.5T GE scanner for purposes of anatomical coregistration with PET. A 3‐h PET scan with 18F‐fallypride (0.07 mCi/Kg) was carried out on each subject and repeated in 4–6 weeks. Arterial or arterialized venous blood was obtained in all subjects in order to evaluate blood activity levels and analyze metabolites in the plasma. Brain regions‐of‐interest were identified and drawn using PET and PET‐MR coregistered images. PET data was analyzed using graphical methods in which cerebellum was used as the reference region providing distribution volume ratios (DVR) from which binding potential (BP) was derived and used as a measure of concentration of receptors. Distribution of 18F‐fallypride was consistent in all subjects studied and the rank order of receptor concentration was putamen > caudate > thalamus = pituitary > amygdala > colliculi > substantia nigra > hippocampus = temporal cortex > parietal cortex = occipital cortex = orbitofrontal cortex. For younger subjects, BP ranged from 37 for the putamen to 0.4 for orbitofrontal cortex, with a test–retest error of about 10%. Both hydrophilic and lipophilic metabolites were observed in arterial blood plasma and analyses showed approx. 30–40% of plasma radioactivity at 3 h was 18F‐fallypride. With aging, all brain regions exhibited a significant decrease (>10% per decade) in binding of 18F‐fallypride. PET studies with 18F‐fallypride are thus suitable to study changes in D2/D3 receptors in striatal and extrastriatal brain regions. Synapse 46:170–188, 2002. © 2002 Wiley‐Liss, Inc.
Number of times cited: 131
- Patricia E. Edem, E. Johanna L. Steen, Andreas Kjær and Matthias M. Herth, Fluorine-18 Radiolabeling Strategies—Advantages and Disadvantages of Currently Applied Labeling Methods, Late-Stage Fluorination of Bioactive Molecules and Biologically-Relevant Substrates, 10.1016/B978-0-12-812958-6.00002-1, (29-103), (2019).
- Jogeshwar Mukherjee, Patrick J. Lao, Tobey J. Betthauser, Gurleen K. Samra, Min‐Liang Pan, Ishani H. Patel, Christopher Liang, Raju Metherate and Bradley T. Christian, Human brain imaging of nicotinic acetylcholine α4β2* receptors using [18F]Nifene: Selectivity, functional activity, toxicity, aging effects, gender effects, and extrathalamic pathways, Journal of Comparative Neurology, 526, 1, (80-95), (2017).
- Kathryn C. Dickerson and R. Alison Adcock, Motivation and Memory, Stevens' Handbook of Experimental Psychology and Cognitive Neuroscience, (1-36), (2018).
- Scott J Moeller, Kyoji Okita, Chelsea L Robertson, Michael E Ballard, Anna B Konova, Rita Z Goldstein, Mark A Mandelkern and Edythe D London, Low Striatal Dopamine D2-type Receptor Availability is Linked to Simulated Drug Choice in Methamphetamine Users, Neuropsychopharmacology, 43, 4, (751), (2018).
- Philippe Pfeifer, Oliver Tüscher, Hans Georg Buchholz, Gerhard Gründer, Ingo Vernaleken, Michael Paulzen, Ulrich S. Zimmermann, Stephan Maus, Klaus Lieb, Thomas Eggermann, Christoph Fehr and Mathias Schreckenberger, Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2/D3 dopamine system, Addiction Biology, 22, 5, (1449-1458), (2016).
- Thomas J. Farrer and Erin D. Bigler, Structural Neuroimaging in Geropsychology, Encyclopedia of Geropsychology, 10.1007/978-981-287-082-7_342, (2294-2301), (2017).
- Christin Y Sander, Joseph B Mandeville, Hsiao-Ying Wey, Ciprian Catana, Jacob M Hooker and Bruce R Rosen, Effects of flow changes on radiotracer binding: Simultaneous measurement of neuroreceptor binding and cerebral blood flow modulation, Journal of Cerebral Blood Flow & Metabolism, (0271678X1772541), (2017).
- C T Smith, L C Dang, J W Buckholtz, A M Tetreault, R L Cowan, R M Kessler and D H Zald, The impact of common dopamine D2 receptor gene polymorphisms on D2/3 receptor availability: C957T as a key determinant in putamen and ventral striatum, Translational Psychiatry, 7, 4, (e1091), (2017).
- Nora S. Vyas, Monte S. Buchsbaum, Douglas S. Lehrer, Brian M. Merrill, Alex DeCastro, Nicholas A. Doninger, Bradley T. Christian and Jogeshwar Mukherjee, D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophrenia, Schizophrenia Research, 10.1016/j.schres.2017.05.017, (2017).
- Linh C. Dang, Jaime J. Castrellon, Scott F. Perkins, Nam T. Le, Ronald L. Cowan, David H. Zald and Gregory R. Samanez-Larkin, Reduced effects of age on dopamine D2 receptor levels in physically active adults, NeuroImage, 148, (123), (2017).
- Shihong Li, Alexander Schmitz, Hsiaoju Lee and Robert H. Mach, Automation of the Radiosynthesis of Six Different 18F-labeled radiotracers on the AllinOne, EJNMMI Radiopharmacy and Chemistry, 10.1186/s41181-016-0018-0, 1, 1, (2016).
- Vishnu P. Murty and R. Alison Adcock, Distinct Medial Temporal Lobe Network States as Neural Contexts for Motivated Memory Formation, The Hippocampus from Cells to Systems, 10.1007/978-3-319-50406-3_15, (467-501), (2017).
- Robert H. Mach, Small Molecule Receptor Ligands for PET Studies of the Central Nervous System—Focus on G Protein Coupled Receptors, Seminars in Nuclear Medicine, 10.1053/j.semnuclmed.2017.05.002, 47, 5, (524-535), (2017).
- Mona Sharma and Anand Kumar, Male Behaviors IV: Ageing Brain, Basics of Human Andrology, 10.1007/978-981-10-3695-8_20, (349-362), (2017).
- Xiaoling Fu, Wenjia Zhu, Zhe Guo, Gangming Shu, Fang Cui, Fei Yang, Ying Zhang, Yuting Ren, Xiaojun Zhang, Xiaolan Zhang, Zhaohui Chen, Li Ling, Xusheng Huang and Jinming Zhang, 18 F-fallypride PET-CT of dopamine D2/D3 receptors in patients with sporadic amyotrophic lateral sclerosis, Journal of the Neurological Sciences, 377, (79), (2017).
- K Okita, A M Morales, A C Dean, M C Johnson, V Lu, J Farahi, M A Mandelkern and E D London, Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users, Molecular Psychiatry, (2017).
- Yu Deok Won, Min Kyun Na, Je-Il Ryu, Jin-Hwan Cheong, Jae-Min Kim, Choong-Hyun Kim and Myung-Hoon Han, Radiologic Factors Predicting Deterioration of Mental Status in Patients with Acute Traumatic Subdural Hematoma, World Neurosurgery, 10.1016/j.wneu.2017.12.025, (2017).
- Ibanylla Kynjai Hynniewta Hadem, Teikur Majaw, Babiangshisha Kharbuli and Ramesh Sharma, Beneficial effects of dietary restriction in aging brain, Journal of Chemical Neuroanatomy, (2017).
- Jogeshwar Mukherjee, Alisha K. Bajwa, Dustin W. Wooten, Ansel T. Hillmer, Min‐Liang Pan, Suresh K. Pandey, Neil Saigal and Bradley T. Christian, Comparative assessment of 18F‐Mefway as a serotonin 5‐HT1A receptor PET imaging agent across species: Rodents, nonhuman primates, and humans, Journal of Comparative Neurology, 524, 7, (1457-1471), (2015).
- Esteban A. Oyarzabal, Yen-Yu Ian Shih and Jau-Shyong Hong, Aging and Microglial Activation in Neurodegenerative Diseases, Inflammation, Aging, and Oxidative Stress, 10.1007/978-3-319-33486-8_7, (107-131), (2016).
- Angela Deutschländer, Christian la Fougère, Kai Boetzel, Nathalie L. Albert, Franz-Josef Gildehaus, Peter Bartenstein, Guoming Xiong and Paul Cumming, Occupancy of pramipexole (Sifrol) at cerebral dopamine D2/3 receptors in Parkinson's disease patients, NeuroImage: Clinical, 10.1016/j.nicl.2016.06.007, 12, (41-46), (2016).
- Andrea Schmitt, Dan Rujescu, Micha Gawlik, Alkomiet Hasan, Kenji Hashimoto, Sylvain Iceta, Marek Jarema, Joseph Kambeitz, Siegfried Kasper, Daniel Keeser, Johannes Kornhuber, Nikolaos Koutsouleris, Rupert Lanzenberger, Berend Malchow, Mohamed Saoud, Marie Spies, Gerald Stöber, Florence Thibaut, Peter Riederer and Peter Falkai, Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics, The World Journal of Biological Psychiatry, 10.1080/15622975.2016.1183043, 17, 6, (406-428), (2016).
- Christopher T. Smith, Linh C. Dang, Ronald L. Cowan, Robert M. Kessler and David H. Zald, Variability in paralimbic dopamine signaling correlates with subjective responses to d-amphetamine, Neuropharmacology, 108, (394), (2016).
- Johanna M. Jarcho, Natasha A. Feier, Jennifer S. Labus, Bruce Naliboff, Suzanne R. Smith, Jui-Yang Hong, Luana Colloca, Kirsten Tillisch, Mark A. Mandelkern, Emeran A. Mayer and Edythe D. London, Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response, NeuroImage: Clinical, 10, (107), (2016).
- Vasiliki Michopoulos, Maylen Perez Diaz and Mark E. Wilson, Social change and access to a palatable diet produces differences in reward neurochemistry and appetite in female monkeys, Physiology & Behavior, 162, (102), (2016).
- Claudia Voelcker-Rehage, Claudia Niemann and Ben Godde, The Chronic Exercise–Cognition Interaction in Older Adults, Exercise-Cognition Interaction, 10.1016/B978-0-12-800778-5.00014-1, (295-320), (2016).
- David Matuskey, Patrick Worhunksy, Elizabeth Correa, Brian Pittman, Jean-Dominique Gallezot, Nabeel Nabulsi, Jim Ropchan, Venkatesh Sreeram, Rohit Gudepu, Edward Gaiser, Kelly Cosgrove, Yu-Shin Ding, Marc N. Potenza, Yiyun Huang, Robert T. Malison and Richard E. Carson, Age-related changes in binding of the D 2/3 receptor radioligand [ 11 C](+)PHNO in healthy volunteers, NeuroImage, 10.1016/j.neuroimage.2016.02.002, 130, (241-247), (2016).
- Kyoji Okita, Nicole Petersen, Chelsea L Robertson, Andy C Dean, Mark A Mandelkern and Edythe D London, Sex Differences in Midbrain Dopamine D2-Type Receptor Availability and Association with Nicotine Dependence, Neuropsychopharmacology, 41, 12, (2913), (2016).
- Kyoji Okita, Dara G. Ghahremani, Doris E. Payer, Chelsea L. Robertson, Mark A. Mandelkern and Edythe D. London, Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals, International Journal of Neuropsychopharmacology, 19, 5, (pyv129), (2016).
- M Kohno, K Okita, A M Morales, C L Robertson, A C Dean, D G Ghahremani, F W Sabb, R A Rawson, M A Mandelkern, R M Bilder and E D London, Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users, Molecular Psychiatry, 21, 11, (1554), (2016).
- Kyoji Okita, Dara G. Ghahremani, Doris E. Payer, Chelsea L. Robertson, Andy C. Dean, Mark A. Mandelkern and Edythe D. London, Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users, Drug and Alcohol Dependence, 161, (163), (2016).
- Dardo Tomasi, Gene‐Jack Wang, Ruiliang Wang, Elisabeth C. Caparelli, Jean Logan and Nora D. Volkow, Overlapping patterns of brain activation to food and cocaine cues in cocaine abusers, Human Brain Mapping, 36, 1, (120-136), (2014).
- Jogeshwar Mukherjee, Cristian C. Constantinescu, Angela T. Hoang, Taleen Jerjian, Divya Majji and Min‐Liang Pan, Dopamine D3 receptor binding of 18F‐fallypride: Evaluation using in vitro and in vivo PET imaging studies, Synapse, 69, 12, (577-591), (2015).
- Thomas J. Farrer and Erin D. Bigler, Structural Neuroimaging in Geropsychology, Encyclopedia of Geropsychology, 10.1007/978-981-287-080-3_342-2, (1-8), (2016).
- D Hernaus, D Collip, Z Kasanova, O Winz, A Heinzel, T van Amelsvoort, S M Shali, J Booij, Y Rong, M Piel, J Pruessner, F M Mottaghy and I Myin-Germeys, No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder, Translational Psychiatry, 5, 4, (e547), (2015).
- A M Morales, M Kohno, C L Robertson, A C Dean, M A Mandelkern and E D London, Gray-matter volume, midbrain dopamine D2/D3 receptors and drug craving in methamphetamine users, Molecular Psychiatry, 20, 6, (764), (2015).
- Kati Alakurtti, Jarkko J Johansson, Juho Joutsa, Matti Laine, Lars Bäckman, Lars Nyberg and Juha O Rinne, Long-Term Test–Retest Reliability of Striatal and Extrastriatal Dopamine D2/3 Receptor Binding: Study with [11C]Raclopride and High-Resolution PET, Journal of Cerebral Blood Flow & Metabolism, 35, 7, (1199), (2015).
- Joseph W Kable and Ifat Levy, Neural markers of individual differences in decision-making, Current Opinion in Behavioral Sciences, 10.1016/j.cobeha.2015.08.004, 5, (100-107), (2015).
- Stephanie Haller, Simon M. Ametamey, Roger Schibli and Cristina Müller, Investigation of the chick embryo as a potential alternative to the mouse for evaluation of radiopharmaceuticals, Nuclear Medicine and Biology, 42, 3, (226), (2015).
- M. Kohno, D. G. Ghahremani, A. M. Morales, C. L. Robertson, K. Ishibashi, A. T. Morgan, M. A. Mandelkern and E. D. London, Risk-Taking Behavior: Dopamine D2/D3 Receptors, Feedback, and Frontolimbic Activity, Cerebral Cortex, 25, 1, (236), (2015).
- Thomas J. Farrer and Erin D. Bigler, Neuroimaging, Encyclopedia of Geropsychology, 10.1007/978-981-287-080-3_342-1, (1-8), (2016).
- James Nairne, Peter B. Iveson and Andreas Meijer, Imaging in Drug Development, , 10.1016/bs.pmch.2014.10.002, (231-280), (2015).
- Rachel Tomer, Heleen A. Slagter, Bradley T. Christian, Andrew S. Fox, Carlye R. King, Dhanabalan Murali, Mark A. Gluck and Richard J. Davidson, Love to Win or Hate to Lose? Asymmetry of Dopamine D2 Receptor Binding Predicts Sensitivity to Reward versus Punishment, Journal of Cognitive Neuroscience, 10.1162/jocn_a_00544, 26, 5, (1039-1048), (2014).
- Sea Young Yoon, Carlos Gay-Antaki, Datta E Ponde, Harish Poptani, Charles H Vite and John H Wolfe, Quantitative, noninvasive, in vivo longitudinal monitoring of gene expression in the brain by co-AAV transduction with a PET reporter gene, Molecular Therapy - Methods & Clinical Development, 1, (14016), (2014).
- Rajendra D. Badgaiyan, Imaging dopamine neurotransmission in live human brain, Dopamine, 10.1016/B978-0-444-63425-2.00007-6, (165-182), (2014).
- Suresh Pandey, Archana Venugopal, Ritu Kant, Robert Coleman and Jogeshwar Mukherjee, 124I-Epidepride: A PET radiotracer for extended imaging of dopamine D2/D3 receptors, Nuclear Medicine and Biology, 41, 5, (426), (2014).
- Chloe Clark‐Papasavas, Joel T. Dunn, Suki Greaves, Andrew Mogg, Rosemary Gomes, Stuart Brownings, Kathy Liu, Bonnita Nwosu, Paul Marsden, John Joemon, Marcel Cleij, Robert Kessler, Robert Howard and Suzanne Reeves, Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography, International Journal of Geriatric Psychiatry, 29, 10, (1001-1009), (2014).
- Steven G. Potkin, David B. Keator, Marilyn L. Kesler-West, Dana D. Nguyen, Theo. G. M. van Erp, Jogeshwar Mukherjee, Nikunj Shah and Adrian Preda, D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder, CNS Spectrums, 19, 02, (176), (2014).
- Johan Lataster, Dina Collip, Jenny Ceccarini, Dennis Hernaus, David Haas, Linda Booij, Jim van Os, Jens Pruessner, Koen Van Laere and Inez Myin-Germeys, Familial Liability to Psychosis Is Associated With Attenuated Dopamine Stress Signaling in Ventromedial Prefrontal Cortex, Schizophrenia Bulletin, 40, 1, (66), (2014).
- Jasmeet Kaur, Armen Khararjian, Robert A. Coleman, Cristian C. Constantinescu, Min-Liang Pan and Jogeshwar Mukherjee, Spinal cord dopamine D2/D3 receptors: in vivo and ex vivo imaging in the rat using 18F/11C-fallypride, Nuclear Medicine and Biology, 41, 10, (841), (2014).
- Peter Brust, Jörg van den Hoff and Jörg Steinbach, Development of 18F-labeled radiotracers for neuroreceptor imaging with positron emission tomography, Neuroscience Bulletin, 30, 5, (777), (2014).
- Elske Vrieze, Jenny Ceccarini, Diego A. Pizzagalli, Guy Bormans, Mathieu Vandenbulcke, Koen Demyttenaere, Koen Van Laere and Stephan Claes, Measuring extrastriatal dopamine release during a reward learning task, Human Brain Mapping, 34, 3, (575-586), (2011).
- Axel Rominger, Paul Cumming, Guoming Xiong, Gabriele Koller, Stefan Förster, Andreas Zwergal, Evangelos Karamatskos, Peter Bartenstein, Christian La Fougère and Oliver Pogarell, Effects of acute detoxification of the herbal blend ‘Spice Gold’ on dopamine D2/3 receptor availability: A [18F]fallypride PET study, European Neuropsychopharmacology, 10.1016/j.euroneuro.2013.01.009, 23, 11, (1606-1610), (2013).
- Rebecca Kuepper, Jenny Ceccarini, Johan Lataster, Jim van Os, Marinus van Kroonenburgh, Joop M. A. van Gerven, Machteld Marcelis, Koen Van Laere, Cécile Henquet and Antonio Verdejo García, Delta-9-Tetrahydrocannabinol-Induced Dopamine Release as a Function of Psychosis Risk: 18F-Fallypride Positron Emission Tomography Study, PLoS ONE, 8, 7, (e70378), (2013).
- Neema Pithia, Neal Gulati, Suresh Pandey, Robert Coleman, Ritu Kant and Jogeshwar Mukherjee, Synthesis and biological evaluation of 18F-Norfallypride in the rodent brain using PET imaging, Nuclear Medicine and Biology, 40, 5, (697), (2013).
- Marie-Anne Peyronneau, Wadad Saba, Sébastien Goutal, Bertrand Kuhnast, Frédéric Dollé, Michel Bottlaender and Héric Valette, [18F]Fallypride: Metabolism studies and quantification of the radiotracer and its radiometabolites in plasma using a simple and rapid solid-phase extraction method, Nuclear Medicine and Biology, 40, 7, (887), (2013).
- Artem Lebedev, Reza Miraghaie, Kishore Kotta, Carroll E. Ball, Jianzhong Zhang, Monte S. Buchsbaum, Hartmuth C. Kolb and Arkadij Elizarov, Batch-reactor microfluidic device: first human use of a microfluidically produced PET radiotracer, Lab Chip, 13, 1, (136), (2013).
- R. Tomer, H. A. Slagter, B. T. Christian, A. S. Fox, C. R. King, D. Murali and R. J. Davidson, Dopamine Asymmetries Predict Orienting Bias in Healthy Individuals, Cerebral Cortex, 10.1093/cercor/bhs277, 23, 12, (2899-2904), (2012).
- Aryandokht Fotros, Kevin F Casey, Kevin Larcher, Jeroen AJ Verhaeghe, Sylvia ML Cox, Paul Gravel, Andrew J Reader, Alain Dagher, Chawki Benkelfat and Marco Leyton, Cocaine Cue-Induced Dopamine Release in Amygdala and Hippocampus: A High-Resolution PET [18F]Fallypride Study in Cocaine Dependent Participants, Neuropsychopharmacology, 38, 9, (1780), (2013).
- Joel T Dunn, Chloe Clark-Papasavas, Paul Marsden, Stacey Baker, Marcel Cleij, Shitij Kapur, Robert Kessler, Robert Howard and Suzanne J Reeves, Establishing Test–Retest Reliability of an Adapted [18F]Fallypride Imaging Protocol in Older People, Journal of Cerebral Blood Flow & Metabolism, 33, 7, (1098), (2013).
- Dennis Hernaus, Dina Collip, Johan Lataster, Jenny Ceccarini, Gunther Kenis, Linda Booij, Jens Pruessner, Koen Van Laere, Ruud van Winkel, Jim van Os, Inez Myin-Germeys and Bernard Le Foll, COMT Val158Met Genotype Selectively Alters Prefrontal [18F]Fallypride Displacement and Subjective Feelings of Stress in Response to a Psychosocial Stress Challenge, PLoS ONE, 8, 6, (e65662), (2013).
- Axel Rominger, Paul Cumming, Guoming Xiong, Gabriele Koller, Guido Böning, Melanie Wulff, Andreas Zwergal, Stefan Förster, Anthonin Reilhac, Ole Munk, Michael Soyka, Björn Wängler, Peter Bartenstein, Christian la Fougère and Oliver Pogarell, [18F]fallypride PET measurement of striatal and extrastriatal dopamine D2/3 receptor availability in recently abstinent alcoholics, Addiction Biology, 17, 2, (490-503), (2011).
- Sarah A. Eisenstein, Jon M. Koller, Marilyn Piccirillo, Ana Kim, Jo Ann V. Antenor‐Dorsey, Tom O. Videen, Abraham Z. Snyder, Morvarid Karimi, Stephen M. Moerlein, Kevin J. Black, Joel S. Perlmutter and Tamara Hershey, Characterization of extrastriatal D2 in vivo specific binding of [18F](N‐methyl)benperidol using PET, Synapse, 66, 9, (770-780), (2012).
- Heleen A. Slagter, Rachel Tomer, Bradley T. Christian, Andrew S. Fox, Lorenza S. Colzato, Carlye R. King, Dhanabalan Murali and Richard J. Davidson, PET Evidence for a Role for Striatal Dopamine in the Attentional Blink: Functional Implications, Journal of Cognitive Neuroscience, 10.1162/jocn_a_00255, 24, 9, (1932-1940), (2012).
- Amira K. Brown, Mark A. Mandelkern, Judah Farahi, Chelsea Robertson, Dara G. Ghahremani, Brittany Sumerel, Nathasha Moallem and Edythe D. London, Sex differences in striatal dopamine D2/D3 receptor availability in smokers and non-smokers, The International Journal of Neuropsychopharmacology, 15, 07, (989), (2012).
- Philippe Millet, Marcelle Moulin-Sallanon, Benjamin B. Tournier, Noé Dumas, Yves Charnay, Vicente Ibáñez and Nathalie Ginovart, Quantification of dopamine D2/3 receptors in rat brain using factor analysis corrected [18F]Fallypride images, NeuroImage, 62, 3, (1455), (2012).
- , Methodology Poster Abstracts, Journal of Cerebral Blood Flow & Metabolism, 10.1038/jcbfm.2012.80, 32, 1_suppl, (S128-S191), (2012).
- Cristian C. Constantinescu, Robert A. Coleman, Min‐Liang Pan and Jogeshwar Mukherjee, Striatal and extrastriatal microPET imaging of D2/D3 dopamine receptors in rat brain with [18F]fallypride and [18F]desmethoxyfallypride, Synapse, 65, 8, (778-787), (2011).
- István Sziklai, Judit Szilvássy and Zoltán Szilvássy, Tinnitus control by dopamine agonist pramipexole in presbycusis patients: A randomized, placebo‐controlled, double‐blind study , The Laryngoscope, 121, 4, (888-893), (2011).
- Ole K. Hjelstuen, Anders Svadberg, Dag E. Olberg and Mark Rosser, Standardization of fluorine-18 manufacturing processes: New scientific challenges for PET, European Journal of Pharmaceutics and Biopharmaceutics, 10.1016/j.ejpb.2011.01.002, 78, 3, (307-313), (2011).
- Magdalena Nord and Lars Farde, Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia, CNS Neuroscience & Therapeutics, 17, 2, (97-103), (2010).
- Yihong Yang, Svetlana Chefer, Xiujuan Geng, Hong Gu, Xi Chen and Elliot A. Stein, Structural and Functional Neuroimaging Methods: Applications to Substance Abuse and Addiction, Neuroimaging in Addiction, (37-82), (2011).
- Johan Lataster, Dina Collip, Jenny Ceccarini, David Haas, Linda Booij, Jim van Os, Jens Pruessner, Koen Van Laere and Inez Myin-Germeys, Psychosocial stress is associated with in vivo dopamine release in human ventromedial prefrontal cortex: A positron emission tomography study using [18F]fallypride, NeuroImage, 58, 4, (1081), (2011).
- Nina Bernow, Igor Yakushev, Christian Landvogt, Hans-Georg Buchholz, Michael N. Smolka, Peter Bartenstein, Klaus Lieb, Gerhard Gründer, Ingo Vernaleken, Mathias Schreckenberger and Christoph Fehr, Dopamine D2/D3 receptor availability and venturesomeness, Psychiatry Research: Neuroimaging, 10.1016/j.pscychresns.2011.01.011, 193, 2, (80-84), (2011).
- Ingo Vernaleken, Lisa Peters, Mardjan Raptis, Robert Lin, Hans-Georg Buchholz, Yun Zhou, Oliver Winz, Frank Rösch, Peter Bartenstein, Dean F Wong, Wolfgang M Scháfer and Gerhard Gründer, The applicability of SRTM in [18F]fallypride PET investigations: Impact of scan durations, Journal of Cerebral Blood Flow & Metabolism, 31, 9, (1958), (2011).
- Axel Rominger, Erika Wagner, Erik Mille, Guido Böning, Mouna Esmaeilzadeh, Björn Wängler, Franz‐Josef Gildehaus, Sebastian Nowak, Ariane Bruche, Klaus Tatsch, Peter Bartenstein and Paul Cumming, Endogenous competition against binding of [18F]DMFP and [18F]fallypride to dopamine D2/3 receptors in brain of living mouse, Synapse, 64, 4, (313-322), (2009).
- Miguel Pérez de la Mora, Andrea Gallegos-Cari, Yexel Arizmendi-García, Daniel Marcellino and Kjell Fuxe, Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: Structural and functional analysis, Progress in Neurobiology, 90, 2, (198), (2010).
- Rachael D. Seidler, Jessica A. Bernard, Taritonye B. Burutolu, Brett W. Fling, Mark T. Gordon, Joseph T. Gwin, Youngbin Kwak and David B. Lipps, Motor control and aging: Links to age-related brain structural, functional, and biochemical effects, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2009.10.005, 34, 5, (721-733), (2010).
- Rachel M Bartlett, Onofre T DeJesus, Todd E Barnhart, R Jerome Nickles, Bradley T Christian, John L Graner and James E Holden, Fetal Dopamine Receptor Characteristics Assessed in Utero, Journal of Cerebral Blood Flow & Metabolism, 30, 8, (1437), (2010).
- Nora S. Vyas, Neva H. Patel, Kuldip S. Nijran, Adil Al-Nahhas and Basant K. Puri, Can PET/CT imaging advance our understanding of the neurobiology of schizophrenia?, Nuclear Medicine Communications, 10.1097/MNM.0b013e3283341830, 31, 2, (91-93), (2010).
- Ingo Vernaleken, Gerhard Gruender and Paul Cumming, Progress in Psychopharmacotherapy though Molecular Imaging, Systems Biology in Psychiatric Research, (189-206), (2010).
- Byung Seok Moon, Jun Hyung Park, Hong Jin Lee, Ji Sun Kim, Hee Sup Kil, Byoung Se Lee, Dae Yoon Chi, Byung Chul Lee, Yu Kyeong Kim and Sang Eun Kim, Highly efficient production of [18F]fallypride using small amounts of base concentration, Applied Radiation and Isotopes, 68, 12, (2279), (2010).
- Andrea Kobiella, Sabine Vollstädt‐Klein, Mira Bühler, Caroline Graf, Hans‐Georg Buchholz, Nina Bernow, Igor Y. Yakushev, Christian Landvogt, Mathias Schreckenberger, Gerhard Gründer, Peter Bartenstein, Christoph Fehr and Michael N. Smolka, Human dopamine receptor D2/D3 availability predicts amygdala reactivity to unpleasant stimuli, Human Brain Mapping, 31, 5, (716-726), (2009).
- Igor Y. Yakushev, Erwan Dupont, Hans‐Georg Buchholz, Julia Tillmanns, Fabian Debus, Paul Cumming, Axel Heimann, Andreas Fellgiebel, Heiko J. Luhmann, Christian Landvogt, Konrad J. Werhahn, Mathias Schreckenberger, Heidrun Potschka and Peter Bartenstein, In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy, Epilepsia, 51, 3, (415-422), (2009).
- Christian Landvogt, Hans‐Georg Buchholz, Viviane Bernedo, Mathias Schreckenberger and Konrad J. Werhahn, Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy, Epilepsia, 51, 9, (1699-1706), (2010).
- Douglas S. Lehrer, Bradley T. Christian, Cemil Kirbas, Meicheng Chiang, Shawn Sidhu, Holly Short, Binquan Wang, Bingzhi Shi, King-Wai Chu, Brian Merrill and Monte S. Buchsbaum, 18F-Fallypride binding potential in patients with schizophrenia compared to healthy controls, Schizophrenia Research, 122, 1-3, (43), (2010).
- David H. Zald, Neil D. Woodward, Ronald L. Cowan, Patrizia Riccardi, M. Sib Ansari, Ronald M. Baldwin, Ronald L. Cowan, Clarence E. Smith, Helene Hakyemez, Rui Li and Robert M. Kessler, The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: A principal component analysis of [18F]fallypride binding, NeuroImage, 51, 1, (53), (2010).
- B. Mazurek, H. Olze, H. Haupt, B.F. Klapp, M. Adli, J. Gross and A.J. Szczepek, Molekularbiologische Aspekte der Neuroplastizität, HNO, 58, 10, (973), (2010).
- Georg Nikisch, Pierre Baumann, Bernhard Kießling, Michael Reinert, Georg Wiedemann, Jan Kehr, Aleksander A. Mathé, Markus Piel, Frank Roesch, Heike Weisser, Peter Schneider and Andreas Hertel, RETRACTED: Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine, Journal of Psychiatric Research, 44, 12, (754), (2010).
- Rajesh Narendran, W. Gordon Frankle, N. Scott Mason, Eugenii A. Rabiner, Roger N. Gunn, Graham E. Searle, Shivangi Vora, Maralee Litschge, Steve Kendro, Thomas B. Cooper, Chester A. Mathis and Marc Laruelle, Positron emission tomography imaging of amphetamine‐induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride, Synapse, 63, 6, (447-461), (2009).
- Paul W Czoty, Natallia V Riddick, H Donald Gage, Mikki Sandridge, Susan H Nader, Sudha Garg, Michael Bounds, Pradeep K Garg and Michael A Nader, Effect of Menstrual Cycle Phase on Dopamine D2 Receptor Availability in Female Cynomolgus Monkeys, Neuropsychopharmacology, 34, 3, (548), (2009).
- Robert M. Kessler, Neil D. Woodward, Patrizia Riccardi, Rui Li, M. Sib Ansari, Sharlett Anderson, Benoit Dawant, David Zald and Herbert Y. Meltzer, Dopamine D2 Receptor Levels in Striatum, Thalamus, Substantia Nigra, Limbic Regions, and Cortex in Schizophrenic Subjects, Biological Psychiatry, 65, 12, (1024), (2009).
- Rajendra D. Badgaiyan, Alan J. Fischman and Nathaniel M. Alpert, Dopamine release during human emotional processing, NeuroImage, 47, 4, (2041), (2009).
- , BrainPET Poster Session: in vivo Pharmacology and Clinical Applications, Journal of Cerebral Blood Flow & Metabolism, 29, 1_suppl, (S346), (2009).
- , BrainPET Poster Session: Kinetic Modeling, Journal of Cerebral Blood Flow & Metabolism, 29, 1_suppl, (S312), (2009).
- Nora D. Volkow, Dardo Tomasi, Gene-Jack Wang, Frank Telang, Joanna S. Fowler, Ruiliang L. Wang, Jean Logan, Christopher Wong, Millard Jayne and James M. Swanson, Hyperstimulation of striatal D2 receptors with sleep deprivation: Implications for cognitive impairment, NeuroImage, 10.1016/j.neuroimage.2009.01.003, 45, 4, (1232-1240), (2009).
- Gisela Johanna Elisabeth Schmitt, Eva Maria Meisenzahl, Thomas Frodl, Christian La Fougère, Klaus Hahn, Hans-Jürgen Möller and Stefan Dresel, Increase of striatal dopamine transmission in first episode drug-naive schizophrenic patients as demonstrated by [123I]IBZM SPECT, Psychiatry Research: Neuroimaging, 173, 3, (183), (2009).
- Victor W. Pike, PET radiotracers: crossing the blood–brain barrier and surviving metabolism, Trends in Pharmacological Sciences, 30, 8, (431), (2009).
- Philip W. Miller, Nicholas J. Long, Ramon Vilar and Antony D. Gee, Synthese von 11C‐, 18F‐, 15O‐ und 13N‐Radiotracern für die Positronenemissionstomographie, Angewandte Chemie, 120, 47, (9136-9172), (2008).
- Vanessa L. Cropley, Robert B. Innis, Pradeep J. Nathan, Amira K. Brown, Janet L. Sangare, Alicja Lerner, Yong Hoon Ryu, Kelly E. Sprague, Victor W. Pike and Masahiro Fujita, Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans, Synapse, 62, 6, (399-408), (2008).
- Henning Boecker, Gjermund Henriksen, Till Sprenger, Isabelle Miederer, Frode Willoch, Michael Valet, Achim Berthele and Thomas R. Tölle, Positron emission tomography ligand activation studies in the sports sciences: Measuring neurochemistry in vivo, Methods, 10.1016/j.ymeth.2008.07.003, 45, 4, (307-318), (2008).
- J.-L. Baulieu, A. Le-Pogam, A. Leborgne, D. Guilloteau and C. Prunier-Aesch, Imagerie moléculaire de la maladie de Parkinson : données actuelles, Médecine Nucléaire, 32, 4, (236), (2008).
- Jan Booij and Paul Kemp, Dopamine transporter imaging with [123I]FP-CIT SPECT: potential effects of drugs, European Journal of Nuclear Medicine and Molecular Imaging, 10.1007/s00259-007-0621-0, 35, 2, (424-438), (2007).
- James C. Eliassen, Erin L. Boespflug, Martine Lamy, Jane Allendorfer, Wen-Jang Chu and Jerzy P. Szaflarski, Brain-Mapping Techniques for Evaluating Poststroke Recovery and Rehabilitation: A Review, Topics in Stroke Rehabilitation, 15, 5, (427), (2008).
- Nora D. Volkow, Gene-Jack Wang, Frank Telang, Joanna S. Fowler, Panayotis K. Thanos, Jean Logan, David Alexoff, Yu-Shin Ding, Christopher Wong, Yeming Ma and Kith Pradhan, Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: Possible contributing factors, NeuroImage, 10.1016/j.neuroimage.2008.06.002, 42, 4, (1537-1543), (2008).
- Philip W. Miller, Nicholas J. Long, Ramon Vilar and Antony D. Gee, Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography, Angewandte Chemie International Edition, 47, 47, (8998-9033), (2008).
- Ted Ruffman, Julie D. Henry, Vicki Livingstone and Louise H. Phillips, A meta-analytic review of emotion recognition and aging: Implications for neuropsychological models of aging, Neuroscience & Biobehavioral Reviews, 32, 4, (863), (2008).
- B. Mazurek, T. Stöver, H. Haupt, J. Gross and A. Szczepek, Die Entstehung und Behandlung der PresbyakusisPathogenesis and treatment of presbyacusis, HNO, 10.1007/s00106-008-1676-3, 56, 4, (429-435), (2008).
- Gayathri J Dowling, Susan R B Weiss and Timothy P Condon, Drugs of Abuse and the Aging Brain, Neuropsychopharmacology, 33, 2, (209), (2008).
- B. Mazurek, T. Stöver, H. Haupt, J. Gross and A. Szczepek, Die Rolle der kochleären Neurotransmitter in Bezug auf TinnitusThe role of cochlear neurotransmitters in tinnitus, HNO, 10.1007/s00106-007-1624-7, 55, 12, (964-971), (2007).
- Jogeshwar Mukherjee, Elizabeth Head, Rama Pichika, Balasubramaniam Easwaramoorthy, Daphne Collins, Ines Chen, Crystal S. Wang, Neil Saigal, Portia Trinidad, Kathy Kim and Vivien L. Nguyen, Radiotracers for a multi‐target approach to the diagnosis of Alzheimer's disease, Journal of Labelled Compounds and Radiopharmaceuticals, 50, 5‐6, (375-379), (2007).
- Nathalie Ginovart, Matthaeus Willeit, Pablo Rusjan, Ariel Graff, Peter M Bloomfield, Sylvain Houle, Shitij Kapur and Alan A Wilson, Positron Emission Tomography Quantification of [11C]-(+)-PHNO Binding in the Human Brain, Journal of Cerebral Blood Flow & Metabolism, 27, 4, (857), (2007).
- Nicolaas I. Bohnen and Kirk A. Frey, Imaging of Cholinergic and Monoaminergic Neurochemical Changes in Neurodegenerative Disorders, Molecular Imaging and Biology, 9, 4, (243), (2007).
- Bradley T. Christian, Douglas S. Lehrer, Bingzhi Shi, Tanjore K. Narayanan, Pamela S. Strohmeyer, Monte S. Buchsbaum and Joseph C. Mantil, Measuring dopamine neuromodulation in the thalamus: Using [F-18]fallypride PET to study dopamine release during a spatial attention task, NeuroImage, 31, 1, (139), (2006).
- Patrizia Riccardi, Rui Li, Mohammad Sib Ansari, David Zald, Sohee Park, Benoit Dawant, Sharlet Anderson, Mikisha Doop, Neil Woodward, Evan Schoenberg, Dennis Schmidt, Ronald Baldwin and Robert Kessler, Amphetamine-Induced Displacement of [18F] Fallypride in Striatum and Extrastriatal Regions in Humans, Neuropsychopharmacology, 31, 5, (1016), (2006).
- Gerhard Gründer, Christian Landvogt, Ingo Vernaleken, Hans-Georg Buchholz, Jasmin Ondracek, Thomas Siessmeier, Sebastian Härtter, Mathias Schreckenberger, Peter Stoeter, Christoph Hiemke, Frank Rösch, Dean F Wong and Peter Bartenstein, The Striatal and Extrastriatal D2/D3 Receptor-Binding Profile of Clozapine in Patients with Schizophrenia, Neuropsychopharmacology, 31, 5, (1027), (2006).
- Robert M Kessler, M Sib Ansari, Patrizia Riccardi, Rui Li, Karuna Jayathilake, Benoit Dawant and Herbert Y Meltzer, Occupancy of Striatal and Extrastriatal Dopamine D2 Receptors by Clozapine and Quetiapine, Neuropsychopharmacology, 31, 9, (1991), (2006).
- M. Mehmet Haznedar, Francesca Roversi, Stefano Pallanti, Nicolo Baldini-Rossi, David B. Schnur, Elizabeth M. LiCalzi, Cheuk Tang, Patrick R. Hof, Eric Hollander and Monte S. Buchsbaum, Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses, Biological Psychiatry, 57, 7, (733), (2005).
- Robert M Kessler, Mohammad Sib Ansari, Patrizia Riccardi, Rui Li, Karuna Jayathilake, Benoit Dawant and Herbert Y Meltzer, Occupancy of Striatal and Extrastriatal Dopamine D2/D3 Receptors by Olanzapine and Haloperidol, Neuropsychopharmacology, 30, 12, (2283), (2005).
- M.A. Lopez-Gonzalez and F. Esteban-Ortega, Tinnitus dopaminergic pathway. Ear noises treatment by dopamine modulation, Medical Hypotheses, 65, 2, (349), (2005).
- Jogeshwar Mukherjee, Bradley T. Christian, Tanjore K. Narayanan, Bingzhi Shi and Daphne Collins, Measurement of d-amphetamine-induced effects on the binding of dopamine D-2/D-3 receptor radioligand, 18F-fallypride in extrastriatal brain regions in non-human primates using PET, Brain Research, 1032, 1-2, (77), (2005).
- Eugenii A. Rabiner, Imaging technologies in drug development: Anxiety and depression, Drug Discovery Today: Technologies, 10.1016/j.ddtec.2005.11.009, 2, 4, (323-327), (2005).
- Mark Slifstein, Raj Narendran, Dah‐Ren Hwang, Yasuhiko Sudo, Peter S. Talbot, Yiyun Huang and Marc Laruelle, Effect of amphetamine on [18F]fallypride in vivo binding to D2 receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies, Synapse, 54, 1, (46-63), (2004).
- Bradley T Christian, Tanjore Narayanan, Bing Shi, Evan D Morris, Joseph Mantil and Jogeshwar Mukherjee, Measuring the in Vivo Binding Parameters of [18F]-Fallypride in Monkeys Using a PET Multiple-Injection Protocol, Journal of Cerebral Blood Flow & Metabolism, 24, 3, (309), (2004).
- JOGESHWAR MUKHERJEE, BINGZHI SHI, T.K. NARAYANAN, B.T. CHRISTIAN and YANG ZHI-YING, Radiopharmaceuticals for Imaging the Brain, Emission Tomography, 10.1016/B978-012744482-6.50008-9, (89-101), (2004).
- Mark Slifstein, Dah-Ren Hwang, Yiyun Huang, NingNing Guo, Yasuhiko Sudo, Raj Narendran, Peter Talbot and Marc Laruelle, In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates, Psychopharmacology, 175, 3, (274), (2004).
- Jogeshwar Mukherjee, Tanjore K. Narayanan, Bradley T. Christian, Bingzhi Shi and Zhi‐Ying Yang, Binding characteristics of high‐affinity dopamine D2/D3 receptor agonists, 11C‐PPHT and 11C‐ZYY‐339 in rodents and imaging in non‐human primates by PET, Synapse, 54, 2, (83-91), (2004).
- Jogeshwar Mukherjee, Bingzhi Shi, Bradley T Christian, Sankha Chattopadhyay and Tanjore K Narayanan, 11C-Fallypride: radiosynthesis and preliminary evaluation of a novel dopamine D2/D3 receptor PET radiotracer in non-human primate brain, Bioorganic & Medicinal Chemistry, 12, 1, (95), (2004).
- Hans Olsson, Christer Halldin and Lars Farde, Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET, NeuroImage, 22, 2, (794), (2004).
- N.Scott Mason and Chester A. Mathis, Positron emission tomography radiochemistry, Neuroimaging Clinics of North America, 13, 4, (671), (2003).
- Anissa Abi-Dargham and Holly Moore, Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia, The Neuroscientist, 9, 5, (404), (2003).




